Gene therapy doubles survival in recurrent glioblastoma

(University of Texas Health Science Center at San Antonio) An experimental gene therapy essentially doubled the overall survival of patients with recurrent glioblastoma compared to the current standard of care, a researcher said Oct. 1 at the Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio.

Source: EurekAlert! - Cancer - October 1, 2015 Category: Cancer & Oncology Source Type: news